Pneumococcal vaccine shows high efficacy rate

11/16/2012 | PhysiciansBriefing.com

A pediatric study of the pneumococcal vaccine PHiD-CV10 showed efficacy rates of 100% and 92% for the 3+1 and 2+1 vaccination schedules, respectively. "For the first time, effectiveness of a 2+1 schedule in infants was confirmed in a clinical trial," Finnish researchers reported in the journal The Lancet.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ
RN Care Manager
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC